Last reviewed · How we verify
silver citrate complex and acemannan — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
silver citrate complex and acemannan (silver citrate complex and acemannan) — CelaCare Technologies, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| silver citrate complex and acemannan TARGET | silver citrate complex and acemannan | CelaCare Technologies, Inc. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- silver citrate complex and acemannan CI watch — RSS
- silver citrate complex and acemannan CI watch — Atom
- silver citrate complex and acemannan CI watch — JSON
- silver citrate complex and acemannan alone — RSS
Cite this brief
Drug Landscape (2026). silver citrate complex and acemannan — Competitive Intelligence Brief. https://druglandscape.com/ci/silver-citrate-complex-and-acemannan. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab